Bach1 Competes with Nrf2 Leading to Negative Regulation of the Antioxidant Response Element (ARE)-mediated NAD(P)H:Quinone Oxidoreductase 1 Gene Expression and Induction in Response to Antioxidants
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The antioxidant response element (ARE) and Nrf2 are known to regulate the expression and coordinated induction of genes encoding detoxifying enzymes including NAD(P)H:quinone oxidoreductase1 (NQO1) in response to antioxidants. In this report, we demonstrate that overexpression of the transcription factor Bach1 in Hep-G2 cells negatively regulated NQO1 gene expression and induction in response to antioxidant t-BHQ. Bandshift and supershift assays revealed that Bach1 binds to the ARE as a heterodimer with small Maf proteins but not as a homodimer or heterodimer with Nrf2. The transfection and ChIP assays revealed that Bach1 and Nrf2 competed with each other to regulate ARE-mediated gene expression. Heme, a negative regulator of Bach1 relieved the Bach1 repression of NQO1 gene expression in transfected cells. The transcription of Bach1 and Nrf2 did not change in response to t-BHQ. Immunofluorescence assays and Western blot analysis revealed that both Bach1 and Nrf2 localized in the cytoplasm and nucleus of the untreated cells. The treatment of cells with t-BHQ resulted in the nuclear accumulation of both Bach1 and Nrf2. Interestingly, the t-BHQ-induced nuclear accumulation of Bach1 was significantly delayed over that of Nrf2. These results led to the conclusion that a balance of Nrf2 versus Bach1 inside the nucleus influences up- or down-regulation of ARE-mediated gene expression. The results further suggest that antioxidant-induced delayed accumulation of Bach1 contributes to the down-regulation of ARE-regulated genes, presumably to reduce the antioxidant enzymes to normal levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![FIG. 3 Bandshift and supershift assays. A , in vitro transcription/translation of Bach1-V5 and MafK proteins. The in vitro transcription/ translation of the pcDNA plasmids encoding Bach1-V5 and MafK were performed using the TNT-coupled Reticulocyte Lysate system by procedures suggested in the manufacturer's protocol. 10 𝛍 l of the translated proteins were resolved on a 10% PAGE gel, treated with Amplify solution (NAMP 10) to enhance the 35 S signal, dried, and autoradiographed. B-E , bandshift assays. NQO1 gene ARE was end-labeled with [ 𝛄 -32 P ]ATP. 50,000 cpm of the labeled ARE were incubated with in vitro translated Bach1-V5 either alone ( B ) or in combination with in vitro translated Nrf2 ( C ) or in combination with in vitro translated small Maf proteins ( D and E ) as shown. The Bach1-V5, Nrf2, and small Maf proteins alone and in combination were preincubated at 37 °C for 15 min before incubation with the labeled NQO1 gene ARE. The bandshift experiment was performed at room temperature. The bandshift reaction mixture was incubated with anti-V5 antibody, Nrf2 antibody or IgG for 2 h at 4 °C. The bandshift and supershift mixtures were analyzed on 5% non-denaturing polyacrylamide gel. The gel was dried and autoradiographed. Double closed arrows indicate shifted and triple closed arrows indicate supershifted bands. Asterisk denotes the nonspecific band from rabbit reticulocyte lysate. F , in vitro translated Bach1 and MafK-V5 proteins were mixed and preincubated without and with cold ARE and mutant ARE. The numbers in parentheses denote the amount in nanograms of cold competitor used. The bandshift assay with labeled NQO1 gene ARE was performed. The bandshift reaction mixture was incubated with anti-V5 antibody for 2 h at 4 °C and analyzed on 5% non-denaturing polyacrylamide gel. The gel was dried and autoradiographed. Asterisk denotes the nonspecific band from rabbit reticulocyte lysate. The arrow indicated a supershifted band with anti-V5 antibody. G , effect of coexpression of Bach1 and MafK on NQO1 gene ARE-mediated luciferase gene expression and induction by tBHQ. The Hep-G2 cells were cotransfected with 0.5 𝛍 g of reporter plasmid NQO1 gene ARE-Luc and 0.05 𝛍 g of expression plasmids pcDNA-Bach1 and pcDNA-MafK either alone and or combined. 0.01 𝛍 g of plasmid pRL-TK encoding Renilla luciferase was used as the internal control in each transfection. The transfected cells were either treated with Me 2 SO or 50 𝛍 M of t-BHQ at 32 h after transfection. The cells were harvested 16 h after the treatment and analyzed for luciferase activity. The values represent mean ± S.E. of three independent transfection experiments.](https://figures.cochat.ai/paper-figures/078de8a2653b4b029dbb4ddb5d588a95/bach1-competes-with-nrf2-leading-to-negative-regulation-of-the-antioxidant-figure-3.png)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rising heme levels induce Bach1 proteosomal degradation, releasing the brake on two types of down-stream pathways. First, the competitive inhibition of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) binding to antioxidant-response elements (ARE) ceases for genes containing AREs [51, 145, 221], such as ferritin h chain (FTH), FPN1, heme-regulated gene-1 (HRG1), and heme oxygenase (Hmox1) [102,”
From “Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels (2017) · cites this paper as [51]
Experimental — accuracy not yet measuredIn the citing paper
“Bach1 competes with Nrf2 in the nucleus for heterodimerization with the sMaf proteins which are required for Nrf2/ARE binding [99].”
From Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease (2022) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634
Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene
Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A. M. K., & Cook, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26071 · Cited by 1,285
Nrf2 signaling in coordinated activation of antioxidant gene expression
Jaiswal, A. K. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.074 · Cited by 1,254
Self-citationChoi, A. M., & Alam, J. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.15.1.8679227 · Cited by 1,126
Venugopal, R., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,040
Self-citationOyake, T., Itoh, K., Motohashi, H., Hayashi, N., Hoshino, H., Nishizawa, M., Yamamoto, M., & Igarashi, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6083 · Cited by 656
Hemoprotein Bach1 regulates enhancer availability of heme oxygenase‐1 gene
Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H., Tashiro, S., Takahashi, S., Shibahara, S., Alam, J., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf516 · Cited by 637
Cited by
Items 101–200 of 423
Hintze, K. J., Katoh, Y., Igarashi, K., & Theil, E. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700254200 · Cited by 110
Kulkarni, S. R., Donepudi, A. C., Xu, J., Wei, W., Cheng, Q. C., Driscoll, M. V., Johnson, D. A., Johnson, J. A., Li, X., & Slitt, A. L. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5082 · Cited by 106
“Hence, ChIP assays were performed on soluble chromatin obtained from Huh-7 cells treated with 8-Br-cAMP using antiSIRT1antibody and analyzed for the presence of DNA containing NQO1 ARE described in (13) using primer sequences as mentioned by the authors.”
InfluentialRegulation of iron pathways in response to hypoxia
Chepelev, N. L., & Willmore, W. G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.023 · Cited by 114
Garofalo, R. P., Kolli, D., & Casola, A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4307 · Cited by 108
“Bach1 is also a basic leucinezipper protein that, similar to Nrf2, binds to small MAF proteins and then to ARE/MARE, acting as a transcriptional repressor (60).”
Hou, W., Tian, Q., Steuerwald, N. M., Schrum, L. W., & Bonkovsky, H. L. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.06.001 · Cited by 103
“, HMOX1 and NAD(P)H:quinone oxidoreductase (NQO1)][6, 8, 9, 13].”
The intricacies of NRF2 regulation in cancer
Schmidlin, C. J., Shakya, A., Dodson, M., Chapman, E., & Zhang, D. D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.016 · Cited by 99
Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells
Pulkkinen, K. H., Ylä‐Herttuala, S., & Levonen, A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.014 · Cited by 104
Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses
Casola, A. (2014) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000141 · Cited by 102
Understanding How Minerals Contribute to Optimal Immune Function
Ştefanache, A., Lungu, I. I., Butnariu, I.-A., Călin, G., Guțu, C., Marcu, C., Grierosu, C., Goroftei, E. R. B., Duceac, L.-D., Dabija, M. G., et al. (2023) · Journal of Immunology Research · doi:10.1155/2023/3355733 · Cited by 123
“Therefore, Nrf2 binds to the promoter region of genes having an antioxidant response element (ARE) and is activated by stressors such as iron-induced ROI and NO [162 – 164].”
BackgroundCopple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_9 · Cited by 104
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Glorieux, C., Enriquez-Lara, C., González, C. D., Aguirre-Martínez, G. V., & Calderón, P. B. (2024) · Antioxidants · doi:10.3390/antiox13010070 · Cited by 103
“In this context, BACH1, a MAF-related transcriptional repressor, can bind to ARE sequences and act as a negative competitor of NRF2 [73,74].”
BackgroundSakamoto, K., Iwasaki, K., Sugiyama, H., & Tsuji, Y. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0762 · Cited by 92
“Competitive binding of Bach1 and Nrf2 on a Mafrecognition element (MARE) or an ARE has been demonstrated previously (Sun et al., 2004; Dhakshinamoorthy et al., 2005), in which Bach1 plays a major role in determining Nrf2 binding to an ARE (Reichard et al.”
BackgroundCytoprotection “gone astray’’: Nrf2 and its role in cancer
Schäfer, H., Geismann, C., Arlt, A., & Sebens, S. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s36624 · Cited by 120
Fratantonio, D., Speciale, A., Ferrari, D., Cristani, M., Saija, A., & Cimino, F. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.09.020 · Cited by 89
Yang, H., Ramani, K., Xia, M., Ko, K. S., Li, T. W. H., Oh, P., Li, J., & Lu, S. C. (2009) · Hepatology · doi:10.1002/hep.22908 · Cited by 91
Chapple, S. J., Keeley, T. P., Mastronicola, D., Arno, M., Vizcay-Barrena, G., Fleck, R., Siow, R. C. M., & Mann, G. E. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.013 · Cited by 87
“Our experiments suggest that upregulation of Bach1 in primary endothelial cells under physiological O2 levels may account for the downregulation of HO-1 and NQO1 induction [12, 50] rather than reduced nuclear Nrf2 translocation (Fig.”
BackgroundTargeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
Tastan, B., Arioz, B. I., & Genç, Ş. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865772 · Cited by 92
Carbon monoxide mediates heme oxygenase 1 induction via Nrf2 activation in hepatoma cells
Lee, B.-S., Heo, J., Kim, Y., Shim, S. M., Pae, H., Kim, Y., & Chung, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.058 · Cited by 89
Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases
Sun, Y., Yang, T., Leak, R. K., Chen, J., & Zhang, F. (2017) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527316666170102120211 · Cited by 92
“Maf proteins are thereby liberated and can form a heterodimer with Nrf2 to enhance the expression of phase II genes (18).”
BackgroundAtamna, H., Frey, W. H., & Ko, N. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.05.003 · Cited by 89
Michaeloudes, C., Chang, P., Petrou, M., & Chung, K. F. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1780oc · Cited by 87
Pharmacologic Induction of Heme Oxygenase-1
Li, C., Hossieny, P., Wu, B. J., Qawasmeh, A., Beck, K., & Stocker, R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1783 · Cited by 94
Heme Oxygenase, Inflammation, and Fibrosis: The Good, the Bad, and the Ugly?
Lundvig, D. M. S., Immenschuh, S., & Wagener, F. A. D. T. G. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00081 · Cited by 85
“Whether and how Bach1 mediates the specific regulation of HO-1 if compared to other ARE-dependent stress response genes such as (NADPH):oxidoreductase-1 (NQO1) or glutathione-S-transferase (GST)-1 is a subject for currently ongoing investigations (Dhakshinamoorthy et al., 2005; MacLeod et al., 2009; Okada et al., 2010…”
Bono, S., Feligioni, M., & Corbo, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00479-8 · Cited by 90
Oxidative stress targets in pulmonary emphysema: focus on the Nrf2 pathway
Boutten, A., Goven, D., Boczkowski, J., & Bonay, M. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003629750 · Cited by 89
“Although Nrf2 is a central player in antioxidant protection, other transcription factors and negative regulators of Nrf2 such as BTB and CNC homology 1, basic leucine zipper transcription factor 1 (Bach1) [65] are involved in the production of endogenous antioxidant enzymes.”
BackgroundChun, K., Kundu, J., Kundu, J. K., & Surh, Y. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.05.018 · Cited by 90
Boyle, J. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328356b145 · Cited by 77
Xing, W., Singgih, A., Kapoor, A., Alarcon, C. M., Baylink, D. J., & Mohan, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702614200 · Cited by 90
SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170
Rezazadeh, S., Yang, D., Tombline, G., Simon, M., Regan, S. P., Seluanov, A., & Gorbunova, V. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz528 · Cited by 81
“The gene expressing HO-1 is one of the NRF2-targeted, ARE-containing genes, where HO-1 catabolizes heme into equimolar amounts of labile Fe, carbon monoxide (CO), and biliverdin (1).”
BackgroundActivation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?
Gugliandolo, A., Bramanti, P., & Mazzon, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144875 · Cited by 83
Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment
Kumar, H., Kumar, R. M., Bhattacharjee, D., Somanna, P., & Jain, V. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.720076 · Cited by 87
“, 2006), BTB and CNC homology 1 (bach1) (Dhakshinamoorthy et al., 2005), caveolin-1 (Li et al.”
Mayer, C., Riera‐Ponsati, L., Kauppinen, S., Klitgaard, H., Erler, J. T., & Hansen, S. N. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1437939 · Cited by 86
Jyrkkänen, H.-K., Kuosmanen, S., Heinäniemi, M., Laitinen, H., Kansanen, E., Mella-Aho, E., Leinonen, H., Ylä-Herttuala, S., & Levonen, A.-L. (2011) · Biochemical Journal · doi:10.1042/bj20110526 · Cited by 78
Normal and Pathological NRF2 Signalling in the Central Nervous System
Heurtaux, T., Bouvier, D. S., Bénani, A., Helgueta, S., Frauenknecht, K. B. M., Mittelbronn, M. G. A., & Sinkkonen, L. (2022) · Antioxidants · doi:10.3390/antiox11081426 · Cited by 89
Boolean modeling and fault diagnosis in oxidative stress response
Sridharan, S., Layek, R. K., Datta, A. A., & Venkatraj, J. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-s6-s4 · Cited by 80
“The pathway segments relevant to the oxidative stress response are given below [9,10,12,15,19,20]: Bach 1, SMP In these pathways ARE represents the family of antioxidant genes in the sense that if the correct complexes bind to ARE it leads to the up-regulation/down-regulation of the appropriate…”
Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes
Kim, K.-H., Jeong, J.-Y., Surh, Y.-J., & Kim, K.-W. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp865 · Cited by 77
“Primer pairs corresponding to the ARE of the NQO1 promoter were used as a positive control (12).”
MethodTudor, C., Lerner-Marmarosh, N., Engelborghs, Y., Gibbs, P. E. M., & Maines, M. D. (2008) · Biochemical Journal · doi:10.1042/bj20080018 · Cited by 78
“Transport of hematin to the nucleus by hBVR would enable its delivery to the transcriptional repressor Bach1, which, on binding hematin dissociates from the DNA, and is replaced by the Nrf2 transcription factor [44,45].”
Heme binding to Amyloid-β peptide: Mechanistic role in Alzheimer's disease
Atamna, H. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-310 · Cited by 77
“Heme is a key prosthetic group in many proteins and regulatory heme, in particular, can function as a signaling molecule [26,27,68,92,96,97,110].”
Ryoo, I.-G., Ha, H., & Kwak, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093265 · Cited by 82
“In particular, other bZIP proteins such as BACH1 and ATF3 can negatively regulate NRF2 activity by inhibiting ARE transactivation [36,37].”
BackgroundDi Domenico, F., Pupo, G., Mancuso, C., Barone, E., Paolini, F., Arena, A., Blarzino, C., Schmitt, F. A., Head, E., Butterfield, D. A., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141254 · Cited by 75
“To extend our results of the consequences of increased Bach1 in DS, we analyzed mRNA and protein levels of NQO1, another well-known protein whose expression is regulated by Bach1 [58].”
Goettsch, C., Göettsch, W., Brux, M., Haschke, C., Brunßen, C., Müller, G. M., Bornstein, S. R., Duerrschmidt, N., Wagner, A. H., & Morawietz, H. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0170-3 · Cited by 77
“The Nrf2 binding site could also be used by other transcription factors including Bach1, thus controlling the balance of ARE-mediated gene expression as shown in other cell types [9].”
BackgroundCore – shell upconversion nanoparticle – semiconductor heterostructures for photodynamic therapy
Dou, Q. Q., Rengaramchandran, A., Selvan, S. T., Paulmurugan, R., & Zhang, Y. (2015) · Scientific Reports · doi:10.1038/srep08252 · Cited by 75
Culletta, G., Buttari, B., Arese, M., Brogi, S., Almerico, A. M., Saso, L., & Tutone, M. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116355 · Cited by 81
Kang, H. J., Hong, Y. B., Kim, H. J., & Bae, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.084590 · Cited by 77
Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling
Sun, X., Zhang, B., Pan, X., Huang, H., Xie, Z., Ma, Y., Hu, B., Wang, J., Chen, Z., & Shi, P. (2019) · The FASEB Journal · doi:10.1096/fj.201900887rr · Cited by 77
“With respect to these processes, many studies have focused on the regulatory mechanisms of Nrf2 and Keap1 (10), glycogen synthase kinase-3 (11), BTB domain and CNC homolog 1 (Bach1) (12), p53 (13), an E3 ubiquitin ligase (Hrd1) (14), and”
BackgroundArmaka, M., Konstantopoulos, D., Tzaferis, C., Lavigne, M. D., Σάκκου, Μ., Liakos, A., Sfikakis, P. P., Dimopoulos, M. A., Fousteri, M. I., & Kollias, G. A. (2022) · Genome Medicine · doi:10.1186/s13073-022-01081-3 · Cited by 75
Nrf2: bane or blessing in cancer?
Xiang, M., Namani, A., Wu, S., & Wang, X. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1627-1 · Cited by 77
Kumar, H., Koppula, S., Kim, I.-S., Vasant More, S., Kim, B.-W., & Choi, D.-K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311211080012 · Cited by 71
Natural Nrf2 Modulators for Skin Protection
Boo, Y. C. (2020) · Antioxidants · doi:10.3390/antiox9090812 · Cited by 69
“demonstrated that BTB domain and CNC homolog 1 (Bach1) binds to ARE as a heterodimer with sMaf proteins but not as a homodimer or heterodimer with Nrf2, and thereby competes with Nrf2 leading to the suppression of ARE-mediated NQO-1 gene expression [50].”
BackgroundKeap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells
Kamble, D., Mahajan, M. R., Dhat, R., & Sitasawad, S. L. (2021) · Cells · doi:10.3390/cells10010083 · Cited by 71
“In the nucleus, Bach1 negatively regulates nuclear Nrf2 activity by competitive-binding with small Maf proteins [9] and thereby inactivates HO1 [10,11].”
BackgroundThe p65 Isoform of Nrf1 Is a Dominant Negative Inhibitor of ARE-mediated Transcription
Wang, W., Kwok, A. M., & Chan, J. Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700159200 · Cited by 69
Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
Telkoparan‐Akillilar, P., Süzen, S., & Saso, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082025 · Cited by 69
Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia
Anzovino, A., Chiang, S., Brown, B. E., Hawkins, C. L., Richardson, D. R., & Huang, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.021 · Cited by 71
Pagano, G., Talamanca, A. A., Castello, G., Pallardó, F. V., Zatterale, A., & Degan, P. (2011) · Biological Chemistry · doi:10.1515/bc-2011-227 · Cited by 74
“BACH1 was found to exert negative regulation of the antioxidant response element (ARE)-mediated NAD(P) H:quinone oxidoreductase 1 gene expression and induction (Dhakshinamoorthy et al. , 2005 ).”
BackgroundNuclear Factor–Erythroid-2–Related Factor 2 in Aging and Lung Fibrosis
Swamy, S., Rajasekaran, N. S., & Thannickal, V. J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.022 · Cited by 69
Kanzaki, H., Shinohara, F., Itohiya, K., Yamaguchi, Y., Katsumata, Y., Matsuzawa, M., Fukaya, S., Miyamoto, Y., Wada, S., & Nakamura, Y. (2016) · The FASEB Journal · doi:10.1096/fj.201600826r · Cited by 69
“Whereas the role of Nrf2 in osteoclastogenesis (12) and regulation of Nrf2 activity by Bach1 (17) were reported, the relationship between ABBREVIATIONS: ALA, 5-aminolevulinic acid; Bach1, BTB and CNC”
BackgroundEmerging roles of Nrf2 signal in non-small cell lung cancer
Tian, Y., Liu, Q., He, X., Yuan, X., Chen, Y., Chu, Q., & Wu, K. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0246-5 · Cited by 66
“In addition, Multidrug resistance-associated 2003 Zhang et al. [46] Cys151, Cys273, Cys288 Sulforaphane, t-BHQ 2002 Dinkova-Kostova et al. [47] Cys257, Cys273, Cys288, Cys297, Cys613 Dexamethasone, sulforaphane 2010 McMahon et al. [49] Cys288, His225, Cys226, Cys613, His129, Lys131, Arg135, Lys150, His154, Cys151 NO,…”
BackgroundInfluentialShen, J., Chen, M., Lee, D., Law, C., Wei, L., Tsang, F. H., Chin, D. W., Cheng, C. L., Lee, J. M., Ng, I. O., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318668 · Cited by 67
Huang, Z., Jebb, D., & Teeling, E. C. (2016) · BMC Genomics · doi:10.1186/s12864-016-3227-8 · Cited by 66
“Bach1, a negative regulator of Nrf2, which is a core activator of the antioxidant response signaling pathway [38].”
BackgroundThe Role of Nrf2 and Cytoprotection in Regulating Chemotherapy Resistance of Human Leukemia Cells
Rushworth, S. A., & MacEwan, D. J. (2011) · Cancers · doi:10.3390/cancers3021605 · Cited by 69
“Upon induction, Bach1 is replaced by Nrf2, resulting in activation and suggesting competition between Bach1 and Nrf2 for the same DNA binding site in different cellular states [27,28].”
BackgroundKeap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer
Renaud, C. O., Ziros, P. G., Chartoumpekis, D. V., Bongiovanni, M., & Sykiotis, G. P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00510 · Cited by 64
Wang, X., Chorley, B. N., Pittman, G. S., Kleeberger, S. R., Brothers, J. F., Liu, G., Spira, A. E., & Bell, D. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011934 · Cited by 64
“NRF1, NRF3, and BACH1 can compete with NRF2 to bind with MAFG at ARE sites, potentially leading to decreased ARE-mediated gene expression [17,18,19].”
BackgroundMartínez, V. D., Vucic, E. A., Pikor, L. A., Thu, K. L., Hubaux, R., & Lam, W. L. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-124 · Cited by 63
“Bach1, competes with NRF2 protein for binding to target genes, leading to inhibited expression of NQO1 and HO-1 for example [17-19].”
Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential
Zolnourian, A. H., Galea, I., & Bulters, D. O. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6218239 · Cited by 65
“BACH1 competes with Nrf2 to bind to ARE and can repress the effects of Nrf2 [127].”
BackgroundDai, L., Cao, Y., Chen, Y., Parsons, C. H., & Qin, Z. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-30 · Cited by 61
“Transcription factors that bind to the ARE include a positive regulator known as Nuclear factor erythroid 2-related factor-2 (Nrf-2) [36] and negative regulators, including BACH-1 and c-Maf, which competitively reduce Nrf-2 binding to the ARE thereby repressing ARE-mediated gene expression [37,38].”
BackgroundLucidone Suppresses Hepatitis C Virus Replication by Nrf2-Mediated Heme Oxygenase-1 Induction
Chen, W., Wang, S., Chiu, C., Tseng, C.-K., Lin, C., Wang, H., & Lee, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02053-12 · Cited by 59
“serves as a transcription repressor (11).”
Michaeloudes, C., Mercado, N., Clarke, C., Bhavsar, P. K., Adcock, I. M., Barnes, P. J., & Chung, K. F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301984 · Cited by 62
“The primers used were as follows: NQO1 forward, 59-CAGTGGCATGCACCCAGGGAA-39, and reverse, 59-GCATGCCCCTTTTAGCCTTGGCA-39 (28), and HO-1 forward, 59-CTGCCCAAACCACTTCTGTT-39, and reverse, 59-ATAAGAAGGCCTCGGTGGAT-39 (29).”
Hao, S., Zhu, X., Liu, Z., Wu, X., Li, S., Jiang, P., & Jiang, L. (2021) · Respiratory Research · doi:10.1186/s12931-021-01655-6 · Cited by 60
“of ROS-related genes, such as heme oxygenase-1 (HO1) [28] and NADPH quinone oxidoreductase 1 (NQO1) [29].”
BackgroundEl‐Magd, N. F. A., & Eraky, S. M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117331 · Cited by 57
Control of Redox State and Redox Signaling by Neural Antioxidant Systems
Lewerenz, J., & Maher, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3600 · Cited by 57
“Thus, modulation of the Bach1–Maf interaction can also play a role in regulating ARE-dependent gene transcription.”
Zhang, Z., Leir, S., & Harris, A. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0263oc · Cited by 56
ApoHRP-based assay to measure intracellular regulatory heme
Atamna, H., Brahmbhatt, M., Atamna, W., Shanower, G., & Dhahbi, J. M. (2015) · Metallomics · doi:10.1039/c4mt00246f · Cited by 56
Langston, W., Circu, M. L., & Aw, T. Y. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.013 · Cited by 55
“Hyperglycemia-stimulated H2O2 production was shown to enhance insulin-induced Akt phosphorylation [48], while diamide-induced GSH depletion and oxidative stress was demonstrated to inhibit the activity of Bach1, an ARE binding transcription factor that negatively regulates Nrf2 [50], thereby promoting Nrf2 signaling […”
BackgroundLiu, D., Duan, X., Dong, D., Bai, C., Li, X., Sun, G., & Li, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/984546 · Cited by 55
Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity
Attucks, O. C., Jasmer, K. J., Hannink, M., Kassis, J., Zhong, Z., Gupta, S., Victory, S. F., Guzel, M., Polisetti, D. R., Andrews, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101044 · Cited by 56
Wu, W., Ma, D., Wang, P., Cao, L., Lu, T., Fang, Q., Zhao, J., & Wang, J. (2015) · FEBS Journal · doi:10.1111/febs.13633 · Cited by 55
MicroRNAs Regulating Reactive Oxygen Species in Cardiovascular Diseases
Gong, Y.-Y., Luo, J., Wang, L., & Huang, Y. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7328 · Cited by 57
“NRF2 transcriptionally activates multiple antioxidant effectors, such as glutathione S -transferase (GST) (55), NAD(P)H:quinone oxidoreductase (NQO) 1 (55), SOD1 (27), and heme oxygenase (HO) 1 (2), through binding to antioxidant response elements (AREs) in their promoters.”
A FoxO1‐dependent, but NRF2‐independent induction of heme oxygenase‐1 during muscle atrophy
Kang, J., Jeong, M. G., Oh, S., Jang, E. J., Kim, H. K., & Hwang, E. S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.009 · Cited by 54
“NRF2 is also suppressed by BACH1, which competitively binds to ARE and suppresses ARE-regulated gene expression [21].”
BackgroundLo, R., & Matthews, J. B. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.03.029 · Cited by 52
Ren, X., Gaile, D. P., Gong, Z., Qiu, W., Ge, Y., Zhang, C., Huang, C.-P., Yan, H., Olson, J. R., Kavanagh, T. J., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.01.014 · Cited by 53
“Bach1 competes with Nfe2l2 for antioxidant response element (ARE), thus leading to negative regulation of Nfe2l2 pathway (Dhakshinamoorthy et al., 2005).”
BackgroundRecognition of BACH1 quaternary structure degrons by two F-box proteins under oxidative stress
Cao, S., Garcia, S. F., Shi, H., James, E. I., Kito, Y., Shi, H., Mao, H., Kaisari, S., Róna, G., Deng, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.10.012 · Cited by 53
“13 14–18 Under oxidative stress, a critical transcription activator, NRF2 (nuclear factor erythroid-derived 2-like 2), accumulates and competes with BACH1 for binding sMAF and AREs.”
Minelli, A., Conte, C., Grottelli, S., Bellezza, I., Cacciatore, I., & Bolaños, J. P. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00326.x · Cited by 50
“NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibition by NO has been shown to be synergistic with glutathione deficiency [32] and the activity of -ketoglutarate dehydrogenase, the enzyme responsible for NADH supply to complex I, is inhibited by H2O2 [33, 34].”
BackgroundCasalino, E., Calzaretti, G., Landriscina, M., Sblano, C., Fabiano, A., & Landriscina, C. (2007) · Toxicology · doi:10.1016/j.tox.2007.04.020 · Cited by 49
Xie, J., He, X., Fang, H., Liao, S., Liu, Y., Tian, L., & Niu, J. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126654 · Cited by 51
Bayele, H. K., Balesaria, S., & Srai, S. K. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.001 · Cited by 50
“Co-transfection of Keap1 [14] or Bach1 [33] with the full-length promoter and Nrf2 showed dose-dependent luciferase repression by Keap1 (Fig.”
BackgroundCOPD lung studies of Nrf2 expression and the effects of Nrf2 activators
Li, J., Baker, J. M., Higham, A., Shah, R. D., Montero, Á., Murray, C. M., Cooper, N., Lucas, C., Fox, C., Singh, D., et al. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00967-3 · Cited by 52
“Due to differences in the presence of ARE enhancer sites at different anti-oxidant genes, the dynamic interplay between Bach1 and Nrf2 can produce distinct regulatory expression (Reichard et al.”
BackgroundInfluentialLiu, X., Li, H., Liu, L., Lu, Y., Gao, Y., Geng, P., Li, X., Huang, B., Zhang, Y., & Lü, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.05.009 · Cited by 51
Association between HO‑1 gene promoter polymorphisms and diseases (Review)
Ma, L., Sun, L., Wang, D., Sun, B.-H., Li, Y., & Jin, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12545 · Cited by 47
Ghaziani, T., Shan, Y., Lambrecht, R. W., Donohue, S. E., Pietschmann, T., Bartenschlager, R. F. W., & Bonkovsky, H. L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.12.020 · Cited by 50
“binding toARE and exert their repressive (Bach1) or activating (Nrf2) effects on ARE-mediated expression of genes encoding anti-oxidant proteins, including HO-1, NQO1, and others [22,47].”
BackgroundThe KEAP1–NRF2 pathway regulates TFEB/TFE3-dependent lysosomal biogenesis
Ong, A. J. S., Bladen, C. E., Tigani, T. A., Karamalakis, A. P., Evason, K. J., Brown, K., & Cox, A. G. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217425120 · Cited by 48
Nrf2: A promising therapeutic target in bone-related diseases
Che, J., Yang, X., Jin, Z., & Xu, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115748 · Cited by 46
Bortezomib induces heme oxygenase-1 expression in multiple myeloma
Barrera, L. N., Rushworth, S. A., Bowles, K. M., & MacEwan, D. J. (2012) · Cell Cycle · doi:10.4161/cc.20343 · Cited by 45
Liu, Y., Yuan, X., Li, W., Cao, Q., & Shu, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2721 · Cited by 45
“…resolvin D1; TGF-β 1, transforming growth factor-β1; EMT, epithelial-to-mesenchymal transition; ROS, reactive oxygen species; Pkm2, pyruvate kinase M2; Nrf2, nuclear factor (erythroid-derived 2)-like 2. to elevated levels of GSH, which enable NADPH to sustain cell proliferation (20,29,30).”
Niu, C., Wang, S., Guo, J., Wei, X., Jia, M., Chen, Z., Gong, W., Qin, Y., Wang, X., Zhi, X., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab034 · Cited by 45
“The transcription factor BTB and CNC homology 1 (BACH1) is widely expressed in most mammalian tissues and has a crucial role in oxidative-stress response (13,14) and cell cycle, as well as mechanisms involved in heme homeostasis, reactive oxygen species production, angiogenesis, and cancer metastasis (15–18).”
BackgroundKropotov, A., Serikov, V. B., Suh, J. H., Smirnova, A., Bashkirov, V. I., Zhivotovsky, B., & Tomilin, N. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05265.x · Cited by 46
Raval, C. M., Zhong, J. L., Mitchell, S. A., & Tyrrell, R. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.494 · Cited by 44
Alarcón‐Aguilar, A., Luna‐López, A., Ventura-Gallegos, J. L., Lazzarini-Lechuga, R. C., Galván‐Arzate, S., González‐Puertos, V. Y., Morán, J., Santamaría, A., & Königsberg, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.143 · Cited by 47
“Bach1 binding to ARE leads to a negative gene expression regulation (Dhakshinamoorthy et al., 2005).”
Bach1 deficiency protects pancreatic β-cells from oxidative stress injury
Kondo, K., Ishigaki, Y., Gao, J., Yamada, T., Imai, J., Sawada, S., Muto, A., Oka, Y., Igarashi, K., & Katagiri, H. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2013 · Cited by 48
“Bach1 forms a heterodimer with small Maf oncoproteins and binds to Maf recognition elements (MAREs) on the genome, thereby inhibiting transcription of oxidative stress-responsive genes, including heme oxygenase-1 (HO-1) (30), NAD(P)H quinone oxidoreductase 1 (2), and thioredoxin reductase 1 (10).”
BackgroundShenvi, S. V., Smith, E., & Hagen, T. M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00788.x · Cited by 43
“First, chromatin from aged cells shows the presence of Bach1, a known transcriptional repressor of ARE-mediated gene expression (Dhakshinamoorthy et al., 2005; Reichard et al., 2007; Kaspar & Jaiswal, 2010).”
BackgroundLam, K. Y. C., Yao, P., Wang, H., Duan, R., Dong, T. T.-X., & Tsim, K. W. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179077 · Cited by 43
Metadata
- Authors
- Dhakshinamoorthy, S., Jain, A. K., Bloom, D. A., & Jaiswal, A. K.
- Affiliations
- Baylor College of Medicine (US)
- Corresponding author
- Jaiswal, Anil K.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 280
- Issue
- 17
- Pages
- 16891-16900
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2093507774
- Cited by
- 414
- References
- 38
- Citations by year
- 2026: 22 · 2025: 18 · 2024: 18 · 2023: 17 · 2022: 26 · 2021: 27 · 2020: 27 · 2019: 24 · 2018: 17 · 2017: 21 · 2016: 16 · 2015: 19 · 2014: 22 · 2013: 21 · 2012: 23
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5677 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of California, San Francisco
- National Institute of General Medical Sciences (GM-47466)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- BACH1, Nrf2, antioxidant response element, NAD(P)H:quinone oxidoreductase 1, NQO1, transcriptional repression, heme, nuclear accumulation, HepG2 cells, antioxidant response, gene expression regulation
- MeSH terms
- Antioxidants, Base Sequence, Binding, Competitive, Cell Line, Cell Nucleus, Cytoplasm, DNA-Binding Proteins, Gene Expression Regulation, Heme, Humans, Kinetics, Luciferases, Microscopy, Fluorescence, Molecular Sequence Data, Plasmids, Promoter Regions, Genetic, Protein Binding, Proto-Oncogene Proteins, RNA, Messenger, Subcellular Fractions, Time Factors, Transcription Factors, Transcription, Genetic, Transfection, Protein Biosynthesis, Blotting, Northern, Blotting, Western, Trans-Activators, Down-Regulation, Up-Regulation, NAD(P)H Dehydrogenase (Quinone), Genes, Reporter, Dimerization, Response Elements, Cell Line, Tumor, Chromatin Immunoprecipitation, Basic-Leucine Zipper Transcription Factors, Proto-Oncogene Proteins c-maf, NF-E2-Related Factor 2, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.